Filters close
Released: 18-Jul-2013 12:00 PM EDT
Weight Loss Drug Helps Curb Cocaine Addictions
Perelman School of Medicine at the University of Pennsylvania

The drug topiramate, typically used to treat epilepsy and more recently weight loss, may also help people addicted to both cocaine and alcohol use less cocaine, particularly heavy users, researchers in the department of Psychiatry at Penn Medicine report in a new study published in Drug and Alcohol Dependence.

16-Jul-2013 12:00 PM EDT
“Not Your Madame’s Isotope” – Safer Radium Therapy Provides Hope for Metastatic Prostate Cancer Patients
Perelman School of Medicine at the University of Pennsylvania

In an editorial accompanying the new results of a trial of Radium-223 in the New England Journal of Medicine, Neha Vapiwala, MD, an associate professor and chief of the Genitourinary service in the department of Radiation Oncology in the Perelman School of Medicine and Abramson Cancer Center at the University of Pennsylvania, revisits the discovery of radium by Madame Marie Curie more than 115 years ago and traces its path to modern-day cancer care.

Released: 16-Jul-2013 3:35 PM EDT
Molecular Relative of p53 Tumor Suppressor Protein also Helps Cancer Cells Thrive
Perelman School of Medicine at the University of Pennsylvania

The protein TAp73 is a relative of the well-known, tumor-suppressor protein p53, yet it is still not known whether TAp73 enhances tumor cell growth and, if so, exactly how. Penn researchers found that TAp73 supports the proliferation of human and mouse tumor cells. They also identify an important mechanism by which TAp73 gives tumor cells a growth advantage: it activates the expression of an enzyme important for cell replications and anti-oxidant protection.

Released: 15-Jul-2013 9:30 AM EDT
Path of Plaque Buildup in Brain Shows Promise as Early Biomarker for Alzheimer’s Disease
Perelman School of Medicine at the University of Pennsylvania

The trajectory of amyloid plaque buildup—clumps of abnormal proteins in the brain linked to Alzheimer’s disease—may serve as a more powerful biomarker for early detection of cognitive decline rather than using the total amount to gauge risk, researchers from Penn Medicine’s Department of Radiology suggest in a new study published online July 15 in Neurobiology of Aging.

Released: 12-Jul-2013 10:00 AM EDT
Penn Study Reveals Promise of “Human Computing Power” via Crowdsourcing to Speed Medical Research
Perelman School of Medicine at the University of Pennsylvania

Utilizing crowdsourcing in medical research can improve the quality, cost, and speed of a research project while engaging large segments of the public and creating novel science.

9-Jul-2013 10:00 AM EDT
Vascular Link in Alzheimer's Disease with Cognition
Perelman School of Medicine at the University of Pennsylvania

Researchers in the Perelman School of Medicine at the University of Pennsylvania found that, across a variety of neurodegenerative diseases, cerebrovascular disease affecting circulation of blood in the brain was significantly associated with dementia.

3-Jul-2013 9:30 AM EDT
Study Sheds Light on Why Low-Income Patients Prefer Hospital Care to a Doctor’s Office
Perelman School of Medicine at the University of Pennsylvania

Patients with low socioeconomic status use emergency and hospital care more often than primary care because they believe hospital care is more affordable and convenient, and of better quality than care provided by primary care physicians, according to the results of a new study from researchers at Penn Medicine. The results of the study, appearing in the July issue of Health Affairs, have significant implications for policy initiatives such as the Affordable Care Act that seek to lower health care costs by reducing avoidable hospitalizations, readmissions, and emergency department visits.

Released: 5-Jul-2013 12:00 PM EDT
Lessons From Across the Pond: Should Radiologists Be the Gatekeepers of Medical Imaging?
Perelman School of Medicine at the University of Pennsylvania

In a New England Journal of Medicine “Perspective” article, Saurabh Jha, MB, BS, of the department of Radiology at in the Perelman School of Medicine at the University of Pennsylvania, discusses an important role for radiologists as changes in the US health care system come about: gatekeepers of medical imaging.

26-Jun-2013 4:00 PM EDT
Shape-Shifting Disease Proteins May Explain Neurodegenerative Variation
Perelman School of Medicine at the University of Pennsylvania

Researchers in the Perelman School of Medicine at the University of Pennsylvania have shown one disease protein can morph into different strains and promote misfolding of other disease proteins commonly found in Alzheimer’s, Parkinson’s and other related neurodegenerative diseases.

27-Jun-2013 1:20 PM EDT
Pre-Existing Insomnia Linked to PTSD and Other Mental Disorders After Military Deployment
Perelman School of Medicine at the University of Pennsylvania

New research from the Perelman School of Medicine at the University of Pennsylvania found military service members who have trouble sleeping prior to deployments may be at greater risk of developing posttraumatic stress disorder (PTSD), depression and anxiety once they return home. The study found that pre-existing insomnia symptoms conferred almost as a large of a risk for those mental disorders as combat exposure.

24-Jun-2013 1:00 PM EDT
Improving Lung Donor Availability and Allocation—Without the Courts
Perelman School of Medicine at the University of Pennsylvania

In the June 25 issue of the Annals of Internal Medicine, Scott Halpern, MD, PhD, MBE, medical ethicist and assistant professor of ≈, Division of Pulmonary, Allergy and Critical Care, at the Perelman School of Medicine at the University of Pennsylvania, discusses the implications of judicial activism in organ donation and suggests several ways to improve the availability and allocation of transplantable organs.

Released: 24-Jun-2013 11:30 AM EDT
Penn Medicine Joins Second Largest Kidney Exchange in History
Perelman School of Medicine at the University of Pennsylvania

Earlier this month, the Hospital of the University of Pennsylvania and the National Kidney Registry, in partnership with 18 transplant centers across the country, successfully completed the second largest kidney exchange in history and the largest to be concluded in under 40 days. Dubbed Chain 221, the swap involved 56 participants (28 donors and 28 recipients). Four patients at Penn Medicine, including two long-lost grade-school friends, participated in the chain – two receiving new, healthy kidneys, and two donating their own kidneys to other recipients in the chain. Of the participating centers, Penn Medicine was the only one in the tri-state region.

Released: 21-Jun-2013 8:00 AM EDT
Potentially Life-Saving Cooling Treatment Rarely Used for Patients Who Suffer in-Hospital Cardiac Arrest
Perelman School of Medicine at the University of Pennsylvania

Therapeutic hypothermia is rarely being used in patients who suffer cardiac arrest while in the hospital, despite its proven potential to improve survival and neurological function, researchers from Penn Medicine report in the June issue of Critical Care Medicine. The findings have implications for the lives of 210,000 patients in U.S. who arrest during hospitalizations each year.

17-Jun-2013 1:15 PM EDT
Pluripotent Stem Cells Made From Pancreatic Cancer Cells Are First Human Model of the Cancer’s Progression
Perelman School of Medicine at the University of Pennsylvania

Pancreatic cancer carries a dismal prognosis. Researchers and clinicians don’t have a non-invasive way to even detect early cells that portent later disease. Scientists have created a research cell line from a patient with advanced pancreatic cancer. This first-of-its-kind human-cell model of pancreatic cancer progression is the first example using induced pluripotent stem cells to model cancer progression directly from a solid tumor and to model pancreatic cancer from early to invasive stages.

Released: 19-Jun-2013 10:00 AM EDT
Staging System in ALS Shows Potential Tracks of Disease Progression
Perelman School of Medicine at the University of Pennsylvania

The motor neuron disease Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's Disease, progresses in a stepwise, sequential pattern which can be classified into four distinct stages, report pathologists with the Perelman School of Medicine at the University of Pennsylvania in the Annals of Neurology.

11-Jun-2013 12:35 PM EDT
Protein Protects Against Breast Cancer Recurrence in Animal Model
Perelman School of Medicine at the University of Pennsylvania

Precisely what causes breast cancer recurrence has been poorly understood. But now a piece of the puzzle has fallen into place: Researchers have identified a key molecular player in recurrent breast cancer – a finding that suggests potential new therapeutic strategies.

Released: 12-Jun-2013 10:00 AM EDT
Stressed Dads Can Affect Offspring Brain Development
Perelman School of Medicine at the University of Pennsylvania

Stress felt by dad—whether as a preadolescent or adult—leaves a lasting impression on his sperm that gives sons and daughters a blunted reaction to stress, according to a new preclinical study in the Journal of Neuroscience by researchers at the University of Pennsylvania. The findings point to a never-before-seen epigenetic link to stress-related diseases such as anxiety and depression passed from father to child.

Released: 7-Jun-2013 11:00 PM EDT
William H. Lipshutz, MD, Named Outstanding Volunteer Clinical Teacher by American College of Physicians
Perelman School of Medicine at the University of Pennsylvania

Penn Medicine gastroenterologist William H. Lipshutz, MD, has been named the 2013 recipient of the Outstanding Volunteer Clinical Teacher Award by the American College of Physicians.

Released: 7-Jun-2013 10:05 AM EDT
Penn Medicine’s Peter Reese, MD, Named a Greenwall Faculty Scholar
Perelman School of Medicine at the University of Pennsylvania

The Greenwall Foundation has named Penn Medicine’s Peter Reese, MD, MSCE, a leading voice for improving organ donor rates and access to transplant, as a 2013 Greenwall Faculty Scholar in Bioethics.

Released: 3-Jun-2013 2:00 PM EDT
Higher-Activity Jobs Tied to Sleep Extremes
Perelman School of Medicine at the University of Pennsylvania

Certain high-activity careers lead to both lower and higher sleep duration, potentially creating or exacerbating health problems.

Released: 3-Jun-2013 7:30 AM EDT
Cancer Drug Shortages Hit 83 Percent of U.S. Oncologists
Perelman School of Medicine at the University of Pennsylvania

Eighty-three percent of cancer doctors report that they’ve faced oncology drug shortages, and of those, nearly all say that their patients’ treatment has been impacted, according to a study from researchers at the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania that will be presented today at the 2013 annual meeting of the American Society of Clinical Oncology (Abstract #CRA6510). The results showed that shortages – which have hit especially hard among drugs to treat pediatric, gastrointestinal and blood cancers – have left physicians surveyed unable to prescribe standard chemotherapies for a range of cancers.

31-May-2013 12:00 PM EDT
Growth Factor That Triggers Hair Follicle Generation Identified
Perelman School of Medicine at the University of Pennsylvania

Researchers in the Perelman School of Medicine at the University of Pennsylvania have determined the role of a key growth factor, found in limited quantities in human skin cells, that helps hair follicles form and regenerate during the wound healing process. When this growth factor, called Fgf9, was overexpressed in a mouse model, there was a two- to three-fold increase in the number of new hair follicles produced. Researchers believe that this growth factor could be used therapeutically for people with various hair and scalp disorders. The study appears in an advance online publication of Nature Medicine.

Released: 2-Jun-2013 7:30 AM EDT
Targeted Therapy Sorafenib Shows Success in Advanced Differentiated Thyroid Cancer Patients
Perelman School of Medicine at the University of Pennsylvania

The kidney and liver cancer drug sorafenib holds metastatic thyroid cancer at bay for nearly twice as long as a placebo, according to results of a randomized phase III trial, which will be presented today by a researcher from the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania in a plenary session during the American Society of Clinical Oncology’s annual meeting (Abstract #4).

Released: 31-May-2013 10:00 AM EDT
Penn Medicine Presents New Research at SLEEP 2013
Perelman School of Medicine at the University of Pennsylvania

Perelman School of Medicine at the University of Pennsylvania clinicians and researchers will be presenting compelling data and giving talks about emerging issues in the field of sleep medicine during SLEEP 2013, in Baltimore, MD, June 2 – 5, 2013.

28-May-2013 12:55 PM EDT
Gene Therapy Gives Mice Broad Protection to Pandemic Flu Strains, Including 1918 Flu
Perelman School of Medicine at the University of Pennsylvania

Researchers have developed a new gene therapy to thwart a potential influenza pandemic. They demonstrated that a single dose of an adeno-associated virus expressing a broadly neutralizing flu antibody into the noses of animal models gives them complete protection and substantial reductions in flu replication when exposed to lethal strains of H5N1 and H1N1 flu virus. These were isolated from samples associated from historic human pandemics – the infamous 1918 flu pandemic and another from 2009.

Released: 29-May-2013 9:35 AM EDT
Frank T. Leone, MD, Named ‘Practitioner of the Year’ by Philadelphia County Medical Society
Perelman School of Medicine at the University of Pennsylvania

Frank T. Leone, MD, MS, associate professor of Medicine and director of the Comprehensive Smoking Treatment Program at the Perelman School of Medicine at the University of Pennsylvania, has been named the 2013 “Practitioner of the Year” by the Philadelphia County Medical Society (PCMS).

20-May-2013 3:00 PM EDT
How Immune System Peacefully Co-Exists with “Good” Bacteria
Perelman School of Medicine at the University of Pennsylvania

The human gut is loaded with helpful bacteria microbes, yet the immune system seemingly turns a blind eye. Now, researchers know how this friendly truce is kept intact. Innate lymphoid cells directly limit the response by inflammatory T cells to commensal bacteria in the gut of mice. Loss of this ILC function effectively puts the immune system on an extended war footing against the commensal bacteria a condition observed in multiple chronic inflammatory diseases.

17-May-2013 3:45 PM EDT
Decisions to Forgo Life Support May Depend Heavily on the ICU Where Patients are Treated
Perelman School of Medicine at the University of Pennsylvania

The decision to limit life support in patients in the intensive care unit (ICU) appears to be significantly influenced by physician practices and/or the culture of the hospital, suggests new findings from researchers at the Perelman School of Medicine at the University of Pennsylvania presented at the American Thoracic Society International Conference on May 21.

16-May-2013 11:40 AM EDT
Having a Nighttime Critical Care Physician in the ICU Doesn’t Improve Patient Outcomes
Perelman School of Medicine at the University of Pennsylvania

Having a nighttime intensivist had no clear benefit on length of stay or mortality for critical care patients, not even patients admitted at night or those with the most critical illnesses at the time of admission, according to new findings from Penn Medicine researchers published in the New England Journal of Medicine.

15-May-2013 11:00 AM EDT
Research Suggests New Role for ECMO in Treating Patients with Cardiac Arrest and Profound Shock
Perelman School of Medicine at the University of Pennsylvania

Procedure traditionally used during heart surgery and in the ICU may show promise as a rescue strategy for select cardiac arrest patients.

15-May-2013 4:50 PM EDT
PARP Inhibitor Shows Activity in Pancreatic, Prostate Cancers Among Patients Carrying BRCA Mutations
Perelman School of Medicine at the University of Pennsylvania

In the largest clinical trial to date to examine the efficacy of PARP inhibitor therapy in BRCA 1/2 carriers with diseases other than breast and ovarian cancer, the oral drug olaparib was found to be effective against advanced pancreatic and prostate cancers. Results of the study, led by researchers from the Perelman School of Medicine at the University of Pennsylvania and Sheba Medical Center in Tel Hashomer, Israel, will be presented during the American Society of Clinical Oncology’s annual meeting in Chicago in early June (Abstract #11024).

15-May-2013 5:00 PM EDT
Study Finds Broad Support for Rationing of Some Types of Cancer Care
Perelman School of Medicine at the University of Pennsylvania

The majority of cancer doctors, patients, and members of the general public support cutting health care costs by refusing to pay for drugs that don’t improve survival or quality of life, according to results of a new study that will be presented by researchers from the Perelman School of Medicine at the University of Pennsylvania during the annual meeting of the American Society of Clinical Oncology in Chicago in early June (Abstract #6518).

Released: 15-May-2013 3:00 PM EDT
Perelman School of Medicine at the University of Pennsylvania Names First Vice Dean for Diversity and Inclusion, Eve J. Higginbotham, MD
Perelman School of Medicine at the University of Pennsylvania

Eve J. Higginbotham, SM, MD, has been named the first Vice Dean for Diversity and Inclusion at the Perelman School of Medicine at the University of Pennsylvania, effective August 1, 2013.

Released: 14-May-2013 1:50 PM EDT
Newly Described Type of Immune Cell and T cells Share Similar Path to Maturity
Perelman School of Medicine at the University of Pennsylvania

Innate lymphoid cells protect boundary tissues such as the skin, lung, and the gut from microbial onslaught. They also have shown they play a role in inflammatory disease. Researchers have found that maturation of ILC2s requires T-cell factor 1 to move forward. They describe in Immunity that one mechanism used to build ILCs is the same as that in T cells. Both cell types use a protein pathway centered on Notch.

9-May-2013 10:00 AM EDT
Researchers Identify Four New Genetic Risk Factors for Testicular Cancer
Perelman School of Medicine at the University of Pennsylvania

A new study in Nature Genetics looking at the genomes of more than 13,000 men identified four new genetic variants associated with an increased risk of testicular cancer, the most commonly diagnosed type in young men today.

10-May-2013 12:00 PM EDT
Mutation Causing Wrong-Way Plumbing Explains One Type of Blue-Baby Syndrome
Perelman School of Medicine at the University of Pennsylvania

Total anomalous pulmonary venous connection, one type of “blue baby” syndrome, is a potentially deadly congenital disorder that occurs when pulmonary veins don’t connect normally to the left atrium of the heart. TAPVC babies are born cyanotic from lack of oxygen. Semaphorin 3d guides the development of endothelial cells and is crucial for normal development of pulmonary veins. Mutations in Sema3d cause embryonic blood vessels to hook up in the wrong way.

Released: 29-Apr-2013 4:00 PM EDT
Penn Medicine Vice Dean Receives Prestigious Translational Science Award for Contributions to Public Health and Policy
Perelman School of Medicine at the University of Pennsylvania

Brian L. Strom, MD, MPH, the executive vice dean for Institutional Affairs in the Perelman School of Medicine at the University of Pennsylvania and professor of Biostatistics and Epidemiology, was recently presented with a National Award for Career Achievement and Contribution to Clinical and Translational Science at the Translational Science 2013 meeting in Washington, D.C.

Released: 26-Apr-2013 12:00 PM EDT
Most People Suffering from PTSD Not Receiving Effective Treatment
Perelman School of Medicine at the University of Pennsylvania

Over the years, evidence-based therapies, like prolonged exposure therapy, have been shown to successfully ameliorate PTSD severity in patients. The trouble is, the majority of these patients haven’t been getting them, researchers report in Psychological Science in the Public Interest.

24-Apr-2013 9:00 AM EDT
Intractable Seizures Halted with Experimental Treatment for Rare Pediatric "Pretzel Syndrome"
Perelman School of Medicine at the University of Pennsylvania

With a better understanding of underlying mechanisms that cause a rare neurodevelopmental disorder in the Old Order Mennonite population, referred to as Pretzel syndrome, a new study reports that five children were successfully treated with a drug that modifies the disease process, minimizing seizures and improving receptive language. The study, by researchers including experts from the Perelman School of Medicine at the University of Pennsylvania, appears in the journal Science Translational Medicine.

23-Apr-2013 2:00 PM EDT
Binge Eating Curbed by Deep Brain Stimulation in Animal Model
Perelman School of Medicine at the University of Pennsylvania

Deep brain stimulation (DBS) in a precise region of the brain appears to reduce caloric intake and prompt weight loss in obese animal models, according to a new study led by researchers at the University of Pennsylvania.

23-Apr-2013 3:00 PM EDT
Anti-Smoking Ads with Strong Arguments, Not Flashy Editing, Trigger Part of Brain That Changes Behavior
Perelman School of Medicine at the University of Pennsylvania

Researchers from the Perelman School of Medicine at the University of the Pennsylvania have shown that an area of the brain that initiates behavioral changes had greater activation in smokers who watched anti-smoking ads with strong arguments versus those with weaker ones, and irrespective of flashy elements, like bright and rapidly changing scenes, loud sounds and unexpected scenario twists. Those smokers also had significantly less nicotine metabolites in their urine when tested a month after viewing those ads, the team reports in a new study published online April 23 in the Journal of Neuroscience.

Released: 19-Apr-2013 2:30 PM EDT
Penn Researcher Receives Prestigious National Clinical Research Award for Breakthrough in Gene Therapy
Perelman School of Medicine at the University of Pennsylvania

A gene therapy study focused on finding a cure for a rare congenital blinding disease has been recognized as one of the ten most outstanding clinical research projects of the year by the Clinical Research Forum (CRF). The study, led by Jean Bennett, MD, Phd, F.M. Kirby professor of Ophthalmology at the University of Pennsylvania School of Medicine, and carried out in collaboration with Penn Medicine’s Albert M. Maguire, MD, and Katherine A. High, MD at The Children’s Hospital of Philadelphia (CHOP), has been presented with the Distinguished Clinical Research Achievement Award, the second highest given in the CRF’s Annual Top 10 Clinical Research Achievement Awards. CRF award winners are cited as the most compelling examples of scientific innovation that results from the nation’s investment in clinical research that can benefit human health and welfare.

Released: 15-Apr-2013 2:00 PM EDT
Penn Medicine Researcher Awarded Prestigious Grand Prix Scientifique by the Institut de France
Perelman School of Medicine at the University of Pennsylvania

Garret FitzGerald MD, FRS, chairman of the Pharmacology Department and director of the Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, has been awarded the 2013 Grand Prix Scientifique by the Institut de France.

9-Apr-2013 3:00 PM EDT
Testing for BRAF Genetic Mutation Beneficial Only in Aggressive Thyroid Cancers
Perelman School of Medicine at the University of Pennsylvania

Late stage thyroid cancer patients with aggressive disease may benefit from a genetic test, but experts caution that use of this test in early stage patients is inappropriate because it is unlikely to lead to better outcomes, according to an accompanying editorial in JAMA co-authored by two Perelman School of Medicine researchers at the University of Pennsylvania.

5-Apr-2013 10:00 AM EDT
Nearly Half of Breast Cancer Patients at High Risk of Carrying BRCA Mutations Do Not Receive Genetic Testing Recommendations from Physicians
Perelman School of Medicine at the University of Pennsylvania

Only 53 percent of newly diagnosed breast cancer patients who were at high risk of carrying a BRCA 1 or BRCA 2 mutation – based on age, diagnosis, and family history of breast or ovarian cancer – reported that their doctors urged them to be tested for the genes, according to a research team from the Perelman School of Medicine at the University of Pennsylvania.

5-Apr-2013 9:50 AM EDT
Research Team Pinpoints Possible Predictive Biomarker for Identifying Patients Who May Respond to Autophagy Inhibitors
Perelman School of Medicine at the University of Pennsylvania

A team led by researchers from the Perelman School of Medicine at the University of Pennsylvania will present findings (Presentation #1679A) during the American Association for Cancer Research Annual Meeting 2013 outlining a potential new strategy for detecting which cancer patients may respond to therapies involving autophagy inhibitors.



close
0.2656